Voloridge Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $196M | Buy |
6,989,299
+2,743,945
| +65% | +$73.1M | 0.79% | 11 |
|
|
2025
Q4 | $106M | Buy |
+4,245,354
| New | +$107M | 0.37% | 47 |
|
|
2025
Q3 | – | Sell |
-1,199,447
| Closed | -$29.1M | – | 1331 |
|
|
2025
Q2 | $29.1M | Sell |
1,199,447
-3,931,695
| -77% | -$91.7M | 0.11% | 247 |
|
|
2025
Q1 | $130M | Buy |
5,131,142
+2,728,457
| +114% | +$71.4M | 0.48% | 29 |
|
|
2024
Q4 | $63.7M | Buy |
2,402,685
+515,836
| +27% | +$14M | 0.23% | 131 |
|
|
2024
Q3 | $54.6M | Buy |
1,886,849
+1,131,935
| +150% | +$33M | 0.2% | 140 |
|
|
2024
Q2 | $21.1M | Buy |
754,914
+374,759
| +99% | +$10.3M | 0.08% | 345 |
|
|
2024
Q1 | $10.5M | Sell |
380,155
-3,338,856
| -90% | -$92.6M | 0.04% | 480 |
|
|
2023
Q4 | $107M | Buy |
+3,719,011
| New | +$112M | 0.42% | 56 |
|
|
2023
Q2 | – | Sell |
-3,092,036
| Closed | -$126M | – | 1514 |
|
|
2023
Q1 | $126M | Buy |
+3,092,036
| New | +$134M | 0.63% | 11 |
|
|
2022
Q4 | – | Sell |
-1,059,923
| Closed | -$46.4M | – | 1588 |
|
|
2022
Q3 | $46.4M | Buy |
+1,059,923
| New | +$51.5M | 0.25% | 97 |
|
|
2022
Q1 | – | Sell |
-424,907
| Closed | -$25.1M | – | 1627 |
|
|
2021
Q4 | $25.1M | Buy |
424,907
+307,890
| +263% | +$15.3M | 0.14% | 194 |
|
|
2021
Q3 | $5.03M | Buy |
117,017
+107,743
| +1,162% | +$4.77M | 0.03% | 678 |
|
|
2021
Q2 | $363K | Buy |
+9,274
| New | +$361K | ﹤0.01% | 1496 |
|
|
2020
Q3 | – | Sell |
-3,241,014
| Closed | -$101M | – | 1444 |
|
|
2020
Q2 | $101M | Buy |
3,241,014
+3,145,585
| +3,296% | +$107M | 1.15% | 7 |
|
|
2020
Q1 | $2.96M | Sell |
95,429
-27,129
| -22% | -$924K | 0.08% | 261 |
|
|
2019
Q4 | $4.56M | Buy |
+122,558
| New | +$4.37M | 0.09% | 298 |
|
|
2019
Q3 | – | Sell |
-86,618
| Closed | -$3.56M | – | 1192 |
|
|
2019
Q2 | $3.56M | Sell |
86,618
-1,178,940
| -93% | -$46.8M | 0.1% | 220 |
|
|
2019
Q1 | $51M | Buy |
+1,265,558
| New | +$50.7M | 1.54% | 8 |
|
|
2017
Q4 | – | Sell |
-462,420
| Closed | -$15.7M | – | 581 |
|
|
2017
Q3 | $15.7M | Sell |
462,420
-908,224
| -66% | -$29.2M | 0.35% | 63 |
|
|
2017
Q2 | $43.7M | Buy |
+1,370,644
| New | +$43.2M | 1.09% | 20 |
|
|
2016
Q3 | – | Sell |
-161,477
| Closed | -$5.39M | – | 315 |
|
|
2016
Q2 | $5.39M | Sell |
161,477
-5,886,114
| -97% | -$188M | 0.15% | 133 |
|
|
2016
Q1 | $170M | Buy |
+6,047,591
| New | +$173M | 3.98% | 2 |
|
|
2015
Q2 | – | Sell |
-460,027
| Closed | -$15.2M | – | 367 |
|
|
2015
Q1 | $15.2M | Buy |
+460,027
| New | +$14.6M | 0.73% | 37 |
|
Other funds holding PFE
VCM
VPM
Voloridge Investment Management's PFE Position: Q1 2026 in Review
Voloridge Investment Management increased its Pfizer (PFE) stake by 65% in Q1 2026, buying an estimated $73.1M and bringing the position to 6,989,299 shares worth $196M. The position accounts for 0.79% of the portfolio, ranked #11.
Voloridge Investment Management first reported a position in PFE in Q1 2015 and has held it in 24 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Voloridge Investment Management held 6,989,299 shares of Pfizer worth $196M as of Q1 2026.
- Voloridge Investment Management bought 2,743,945 Pfizer shares in Q1 2026, an estimated $73.1M.
- Pfizer made up 0.79% of Voloridge Investment Management's portfolio in Q1 2026, its #11 holding.
- Voloridge Investment Management first reported a position in Pfizer in Q1 2015 and has held it in 24 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.